ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ARQL ArQule Inc

20.00
0.00 (0.00%)
05 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
ArQule Inc NASDAQ:ARQL NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 20.00 19.99 19.50 0 00:00:00

Moore Kuehn, PLLC Encourages Investors of KEM, ARQL, THOR, and LOGM to Contact the Firm

06/01/2020 4:07pm

PR Newswire (US)


ArQule (NASDAQ:ARQL)
Historical Stock Chart


From Dec 2019 to Dec 2024

Click Here for more ArQule Charts.

NEW YORK, Jan. 6, 2020 /PRNewswire/ -- Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders:

(PRNewsfoto/Moore Kuehn, PLLC)

KEMET Corp. (NYSE: KEM)

The investigation concerns possible breaches of fiduciary duty and other violations of law by the Board of KEMET in connection with the proposed sale of KEMET to Yageo. Under the terms of the proposed sale, KEMET shareholders will receive $27.20 per share.

ArQule, Inc. (NASDAQ: ARQL)

The investigation concerns possible breaches of fiduciary duty and other violations of law by the Board of ArQule in connection with the proposed sale of ArQule to a subsidiary of Merck & Co., Inc. (NYSE: MRK). Under the terms of the acquisition agreement, ARQL shareholders will receive $20 per share. 

Synthorx, Inc. (NASDAQ: THOR)

The investigation concerns possible breaches of fiduciary duty and other violations of law by the Board of Synthorx in connection with the proposed sale of Synthorx to Sanofi. Under the terms of the proposed sale, shareholders of Synthorx will receive $68.00 per share. 

LogMeIn, Inc. (NASDAQ: LOGM)

The investigation concerns possible breaches of fiduciary duty and other violations of law by the Board of LogMeIn in connection with the proposed sale of LogMeIn to affiliates of Francisco Partners and Evergreen Coast Capital.  Under the terms of the proposed sale, LogMeIn shareholders will receive $86.05 per share.

Moore Kuehn is investigating whether the Boards of the above companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process.  Moore Kuehn may ultimately seek an increased share price, additional disclosures, or other relief and benefits on behalf of the shareholders of these companies.

Moore Kuehn encourages shareholders to contact Fletcher Moore, Esq. by email at fmoore@moorekuehn.com or telephone at (212) 709-8245.  It is free and there is no cost or obligation to you.

Moore Kuehn is a New York-based law firm with attorneys representing investors and consumers in class action litigation involving securities law violations, financial fraud, breaches of fiduciary duties, and other claims.  For additional information about Moore Kuehn, please go to http://www.moorekuehn.com/practice/new-york-securities-litigation/.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Moore Kuehn, PLLC
Fletcher Moore, Esq.
30 Wall Street, 8th Floor
New York, New York 10005
fmoore@moorekuehn.com 
(212) 709-8245

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/moore-kuehn-pllc-encourages-investors-of-kem-arql-thor-and-logm-to-contact-the-firm-300981750.html

SOURCE Moore Kuehn, PLLC

Copyright 2020 PR Newswire

1 Year ArQule Chart

1 Year ArQule Chart

1 Month ArQule Chart

1 Month ArQule Chart

Your Recent History

Delayed Upgrade Clock